# Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application

> **NCT07679256** · — · RECRUITING · sponsor: **Fujian Medical University Union Hospital** · enrollment: 700 (estimated)

## Conditions studied

- PARKINSON DISEASE (Disorder)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07679256
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07679256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07679256, "Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07679256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*